What the label lists and what reports show
Technetium tc 99m red blood cells side effects
Technetium tc 99m red blood cells's FDA label lists its adverse reactions in its own words. FAERS holds 111 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is radioisotope scan abnormal (15 reports).
- No generic listed
Check it at the source: the technetium tc 99m red blood cells FDA label on DailyMed (effective July 2, 2025); the FDA FAERS public dashboard.
What does the label list?
From the label: adverse reactionsNone known.
Source: FDA drug label, Curium US LLC, effective July 2, 2025 (SPL set 9f999b75-8a66-40bf-9352-478850b41225), via openFDA; the full label on DailyMed
What do FAERS reports show?
111 reports list technetium tc 99m red blood cells among the medicines taken, each a report of something that happened, not proof the medicine caused it; 3 are coded as a death and 0 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 23 reactions below, 1 is named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.
The 25 most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms
What next?
- Technetium tc 99m red blood cells: the full record
- label, generics, price, shortages, recalls
- Report a side effect to the FDA
- MedWatch
- Side effects hub
- the most reported medicines and reactions